PB Ratio: 2.04

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 2.04 is 18% below its estimated 1-year average of 2.48, near the low end of its estimated 1-year range (1.79–3.52).

As of 2026-10-06T12:05:24.747Z.

AKTS PB Ratio Metrics

P/B vs. estimated history

At 2.04, P/B is below its estimated 1-year median — higher than 14% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Aktis Oncology, Inc. (AKTS)?

The P/B ratio for AKTS stock is 2.04.

Is Aktis Oncology, Inc.'s P/B ratio high or low?

The P/B ratio of 2.04 is 18% below its estimated 1-year average of 2.48, near the low end of its estimated 1-year range (1.79–3.52).

Related Metrics